{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:43:54Z","timestamp":1781304234364,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The extraesophageal manifestations of gastroesophageal reflux disease (GERD) are more difficult to manage than the typical symptoms. The efficacy of high-dose and standard-dose proton pump inhibitors against these atypical symptoms is not yet established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single center, randomized, open-label study, patients with GERD received rabeprazole for 8\u2009weeks, either 20\u2009mg once daily (standard-dose group) or 20\u2009mg twice daily (high-dose group). Patients were assessed before treatment and at weeks 4 and 8 with a 5-graded scale questionnaire consisting of 2 typical symptoms (heartburn and acid regurgitation) and 8 atypical symptoms (chest pain, cough, globus, wheezing, laryngopharyngitis, hoarseness, belching, and dysphagia). Sufficient improvement of reflux symptoms was defined as \u226550% reduction from the initial questionnaire score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Final analyses included 35 patients in the standard-dose group and 38 patients in the high-dose group. The rate of sufficient improvement for typical symptoms was significantly higher in the high-dose group than in the standard-dose group (100.0% vs. 84.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.040). For atypical symptoms, the rate of sufficient improvement tended to be higher in the high-dose group than in the standard-dose group (82.4% vs. 63.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.087). Scores of typical and some atypical symptoms (cough and globus) improved after treatment, with significant inter-group differences in time-course changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High-dose rabeprazole is more effective for relieving typical GERD symptoms and some atypical symptoms such as cough and globus than a standard-dose regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This research was enrolled in a registry of clinical trials run by United States National Library of Medicine at the National Institutes of Health (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      Protocol Registration and Results system ID:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04001400\">NCT04001400<\/jats:ext-link>\n                      ). This study was registered on June 26, 2019 - Retrospectively registered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01410-z","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T06:03:21Z","timestamp":1597730601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Jae Ho","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Min","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-410X","authenticated-orcid":false,"given":"Dong Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"issue":"8","key":"1410_CR1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J. Jones R; global consensus group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900\u201320.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1410_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000854","volume":"51","author":"R Hunt","year":"2017","unstructured":"Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, et al. World gastroenterology organisation global guidelines: GERD global perspective on Gastroesophageal reflux disease. J Clin Gastroenterol. 2017;51(6):467\u201378.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1410_CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871\u201380.","journal-title":"Gut."},{"issue":"5","key":"1410_CR4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke 3rd","year":"1997","unstructured":"Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112(5):1448\u201356.","journal-title":"Gastroenterology."},{"issue":"4","key":"1410_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1572-0241.2005.41245.x","volume":"100","author":"YS Cho","year":"2005","unstructured":"Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100(4):747\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1410_CR6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cgh.2018.02.001","volume":"16","author":"MF Vaezi","year":"2018","unstructured":"Vaezi MF, Katzka D, Zerbib F. Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now? Clin Gastroenterol Hepatol. 2018;16(7):1018\u201329.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1410_CR7","first-page":"590","volume":"8","author":"E Saritas Yuksel","year":"2012","unstructured":"Saritas Yuksel E, Vaezi MF. New developments in extraesophageal reflux disease. Gastroenterol Hepatol. 2012;8(9):590\u20139.","journal-title":"Gastroenterol Hepatol"},{"issue":"9","key":"1410_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/MCG.0000000000000918","volume":"51","author":"F Zerbib","year":"2017","unstructured":"Zerbib F, Dulery C. Facts and fantasies on Extraesophageal reflux: a gastroenterologist perspective. J Clin Gastroenterol. 2017;51(9):769\u201376.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1410_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10620-006-9573-7","volume":"52","author":"MP Dore","year":"2007","unstructured":"Dore MP, Pedroni A, Pes GM, Maragkoudakis E, Tadeu V, Pirina P, et al. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci. 2007;52(2):463\u20138.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1410_CR10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1572-0241.2005.41657.x","volume":"100","author":"F Cremonini","year":"2005","unstructured":"Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005;100(6):1226\u201332.","journal-title":"Am J Gastroenterol"},{"key":"1410_CR11","first-page":"CD004823","volume":"1","author":"AB Chang","year":"2011","unstructured":"Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2011;1:CD004823.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1410_CR12","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2006.00844.x","volume":"101","author":"MA Qadeer","year":"2006","unstructured":"Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646\u201354.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1410_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2006.03213.x","volume":"25","author":"L Gatta","year":"2007","unstructured":"Gatta L, Vaira D, Sorrenti G, Zucchini S, Sama C, Vakil N. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;25(4):385\u201392.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1410_CR14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1034\/j.1399-3003.2000.16d11.x","volume":"16","author":"K TO","year":"2000","unstructured":"TO K, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000;16(4):633\u20138.","journal-title":"Eur Respir J"},{"issue":"(5) Suppl 1","key":"1410_CR15","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/S0016-5085(01)80080-9","volume":"120","author":"S Langevin","year":"2001","unstructured":"Langevin S, Hanh N. GERD-induced ENT symptoms: A prospective placebo controlled study with omeprazole 40 mg a day. Gastroenterology. 2001;120((5) Suppl 1):A16.","journal-title":"Gastroenterology"},{"issue":"9","key":"1410_CR16","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1572-0241.2006.00693.x","volume":"101","author":"JM Wo","year":"2006","unstructured":"Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol. 2006;101(9):1972\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1410_CR17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2500\/ajr.2007.21.3098","volume":"21","author":"S Pawar","year":"2007","unstructured":"Pawar S, Lim HJ, Gill M, Smith TL, Merati A, Toohill RJ, Loehrl TA. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study. Am J Rhinol. 2007;21(6):695\u2013701.","journal-title":"Am J Rhinol"},{"issue":"4","key":"1410_CR18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1572-0241.2001.03681.x","volume":"96","author":"HB El-Serag","year":"2001","unstructured":"El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001;96(4):979\u201383.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1410_CR19","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/00005537-200112000-00013","volume":"111","author":"JP Noordzij","year":"2001","unstructured":"Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, Levine PA. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope. 2001;111(12):2147\u201351.","journal-title":"Laryngoscope."},{"issue":"11","key":"1410_CR20","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1111\/j.1572-0241.1999.01504.x","volume":"94","author":"TM Ours","year":"1999","unstructured":"Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94(11):3131\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1410_CR21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cgh.2010.03.009","volume":"8","author":"PK Lam","year":"2010","unstructured":"Lam PK, Ng ML, Cheung TK, Wong BY, Tan VP, Fong DY, et al. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol. 2010;8(9):770\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1410_CR22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","volume":"116","author":"MF Vaezi","year":"2006","unstructured":"Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006;116(2):254\u201360.","journal-title":"Laryngoscope."},{"issue":"4","key":"1410_CR23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.otohns.2004.03.037","volume":"131","author":"DL Steward","year":"2004","unstructured":"Steward DL, Wilson KM, Kelly DH, Patil MS, Schwartzbauer HR, Long JD, Welge JA. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg. 2004;131(4):342\u201350.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"1410_CR24","first-page":"243","volume":"3","author":"T Havas","year":"1999","unstructured":"Havas T, Huang S, Levy M, Abi-Hanna D, et al. Posterior pharyngolaryngitis: double blind randomized placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryng. 1999;3(3):243\u20136.","journal-title":"Aust J Otolaryng"},{"issue":"5","key":"1410_CR25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00365520310001860","volume":"38","author":"AJ Eherer","year":"2003","unstructured":"Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol. 2003;38(5):462\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1410_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2036.2010.04511.x","volume":"33","author":"NJ Shaheen","year":"2011","unstructured":"Shaheen NJ, Crockett SD, Bright SD, Madanick RD, Buckmire R, Couch M, et al. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33(2):225\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1410_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.12-1788","volume":"143","author":"PJ Kahrilas","year":"2013","unstructured":"Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143(3):605\u201312.","journal-title":"Chest."},{"issue":"4","key":"1410_CR28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0889-8553(05)70094-7","volume":"28","author":"MB Fennerty","year":"1999","unstructured":"Fennerty MB. Extraesophageal gastroesophageal reflux disease. Presentations and approach to treatment. Gastroenterol Clin N Am. 1999;28(4):861\u201373.","journal-title":"Gastroenterol Clin N Am"},{"issue":"7","key":"1410_CR29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.MLG.0000163746.81766.45","volume":"115","author":"W Park","year":"2005","unstructured":"Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115(7):1230\u20138.","journal-title":"Laryngoscope."},{"issue":"10","key":"1410_CR30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200910-1537OC","volume":"181","author":"K TO","year":"2010","unstructured":"TO K, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med. 2010;181(10):1042\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1410_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2036.2011.04904.x","volume":"35","author":"T Hershcovici","year":"2012","unstructured":"Hershcovici T, Achem SR, Jha LK, Fass R. Systematic review: the treatment of noncardiac chest pain. Aliment Pharmacol Ther. 2012;35(1):5\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1410_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","volume":"111","author":"D Armstrong","year":"1996","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111(1):85\u201392.","journal-title":"Gastroenterology."},{"issue":"2","key":"1410_CR33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172\u201380.","journal-title":"Gut."},{"issue":"8","key":"1410_CR34","first-page":"1459","volume":"62","author":"Y Hoshihara","year":"2004","unstructured":"Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho. 2004;62(8):1459\u201364 [Article in Japanese].","journal-title":"Nippon Rinsho"},{"issue":"2","key":"1410_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-006-1775-4","volume":"41","author":"M Hongo","year":"2006","unstructured":"Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41(2):95\u20139.","journal-title":"J Gastroenterol"},{"issue":"4","key":"1410_CR36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0002-9343(94)90061-2","volume":"96","author":"PL Kamel","year":"1994","unstructured":"Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1994;96(4):321\u20136.","journal-title":"Am J Med"},{"issue":"4","key":"1410_CR37","first-page":"25","volume":"7","author":"MF Vaezi","year":"2005","unstructured":"Vaezi MF. Atypical manifestations of gastroesophageal reflux disease. MedGenMed. 2005;7(4):25.","journal-title":"MedGenMed."},{"issue":"3","key":"1410_CR38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpg.2013.06.005","volume":"27","author":"PJ Kahrilas","year":"2013","unstructured":"Kahrilas PJ, Boeckxstaens G, Smout AJ. Management of the patient with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol. 2013;27(3):401\u201314.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"1410_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1572-0241.2005.41210.x","volume":"100","author":"S Charbel","year":"2005","unstructured":"Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100(2):283\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1410_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14740330802622892","volume":"8","author":"A Dadabhai","year":"2009","unstructured":"Dadabhai A, Friedenberg FK. Rabeprazole: a pharmacologic and clinical review for acid-related disorders. Expert Opin Drug Saf. 2009;8(1):119\u201326.","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"1410_CR41","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/gut.2004.048884","volume":"54","author":"RE Clouse","year":"2005","unstructured":"Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut. 2005;54(9):1332\u201341.","journal-title":"Gut."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01410-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T19:24:27Z","timestamp":1629228267000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01410-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01410-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23116\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23116\/v2","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"20 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Institutional Review Board of Seoul National University Bundang Hospital (B-1008-110-005). All study participants provided written informed consent prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}